In recent years, several major subsets of CD4+ T helper (Th) cells, such as Th1, Th2 and Th17 cells, have been shown to play an important role in the development of HBV-induced liver inflammation [5] [6] [7] . Th9 cells are a novel subset of CD4+ Th cells that primarily produce IL-9 8, 9 . Th9 cells are capacity for modulating host responses via interacting with different T cell populations, and exert either pro-or anti-inflammatory activities 10, 11 . There is accumulating evidence that Th9 cells contribute to the exacerbation of a wide variety of inflammatory diseases such as allergy and experimental autoimmune encephalomyelitis 12, 13 , whereas they play a protective role in preventing tumorigenesis 14 . More recently, evidence has demonstrated that Th9 cells and related cytokines may be implicated in chronic liver injury, including hepatic fibrogenesis, acuteon-chronic liver failure 15, 16 . However, the change in Th9 expression in the peripheral blood and the subsequent impact on the development of chronic HBV infection have not yet been characterized.
In this study, we investigated the change in the percentage of Th9 cells following HBV infection. We further analyzed the association between Th9 cells and clinical parameters in patients with chronic HBV infection.
| PATIENTS AND METHODS

| Patients
A total of 22 patients were recruited at Shijiazhuang Fifth Hospital, were all excluded. Sixteen healthy volunteers, who came to the hospital for physical check-ups, were recruited as the control group. All healthy controls (HC) were negative for HBV, HCV or HIV infection and had normal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. The study protocol was approved by the ethics committee of Shijiazhuang Fifth Hospital. The methods used in relation with humans were carried out in accordance with the approved guidelines.
| Flow cytometric analysis
Peripheral blood mononuclear cells were isolated from venous blood by ficoll density gradient centrifugation using human lymphocyte separation medium (Solarbio Science & Technology, Beijing, China). Cells were stimulated using phorbol 12-myristate 13-acetate (50 ng/mL, Multisciences, Hangzhou, China), ionomycin (1 μg/mL, Multisciences) and Golgistop (2 μmol/L, Beckton Dickinson, San Diego, CA, USA) for 4 hour at 37°C. Following CD4 and CD8 staining, the cells were fixed and permeabilized according to manufacturer's instructions, and then were intracellularly stained with PE-conjugated anti-human IL-9 mAb (BioLegend, San Diego, CA, USA) and PE-Cy7-conjugated anti-human 
| Cytokine analysis by ELISA
The levels of IL-9 and IL-10 in serum were determined using a commercial ELISA kit (MultiSciences, Hangzhou, Zhejiang, China) according to the manufacturer`s instructions. Cytokine concentrations were calculated using the standard curve obtained for each ELISA plate. loads were determined by real-time PCR using an ABI7500 quantitative PCR instrument (Applied Biosystems, Foster city, CA, USA) with a low detection limit of 500 copies/mL.
|
| Statistical analysis
Data were expressed as the mean±SD. Comparison of differences were carried out using Student's t test, Mann-Whitney U test or Chi-square test. Spearman rank correlation tests were performed for correlation analysis. All data were analyzed using SPSS 19.0 software (SPSS Inc, Chicago, IL, USA). A P values less than 0.05 was considered to be significant.
| RESULTS
| Clinical baseline characteristics of study populations
The demographic and clinical characteristics of subjects from CHB and HC were summarized in (59.1%) were males and 9 (40.9%) were females, with mean ages of (48.14±10.34) years. All patients with chronic HBV infection were positive for HBsAg and HBV DNA. In addition, nine males and seven females with mean ages of (47.27±5.31) years were included as HC.
The patients with chronic HBV infection were comparable to HC with respect to sex and age. 
| The serum levels of IL-9 and IL-10 in CHB patients and HC
The level of IL-9 was relatively decreased, whereas the level of IL-10 was significantly increased in CHB patients when compared with HC ( Figure 5A and 5B). Moreover, the levels of both IL-9 and IL-10 had a positive correlation with HBV DNA loads.
| DISCUSSION
Immune-mediated liver injury is an important pathogenesis of HBV infection 3, 4 . Increasing evidences have shown that CD4+ T cell subset plays an important role in the development of liver inflammation, and an inadequate CD4+ T cell response can result in persistent .
Following Th17 populations are identified, a number of studies have reported that the changes of Treg/Th17, Th1/Th17, and Th22/Th17 ratios are associated with the progression of HBV infection 6, 7, 30 . In the present study, we found a significant increased Th1/Th9 proportion, . Therefore, it is necessary to furthermore study the major producing cells of IL-9 and IL-10 during
Regarding the relationship between Th9 and Th1 cells, it has been demonstrated that IL-9 can decrease production of IL-12 and limit the capacity of APCs to induce a Th1 immune response. Moreover, neutralization of IL-9 enhances IFN-γ production 33 , and IL-9-deficient mice have an upregulated Th1 gene expression 34 . In contrast, IFN-γ inhibits Th9 cell differentiation and IL-9 secretion in human CD4+ T cells 30 . In our study, however, no significant correlation was found between Th9 and Th1 cells in patients with chronic HBV infection.
In addition, there was no significant difference in percentage of Th1 cells between CHB patients and healthy controls. These results suggested that the change in Th1/Th9 ratio might be mainly due to impairment of Th9 cells caused by chronic HBV infection.
In summary, this study demonstrated that the frequency of circu- 
